Article List

WPRIM Management System> DCMS> Radiation Oncology Journal> 2017> 35> 2

1. Extraordinary radiation super-sensitivity accompanying with sorafenib combination therapy: what lies beneath?.	Page:185—188
2. Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States.	Page:137—143
3. Effect of time interval between capecitabine intake and radiotherapy on local recurrence-free survival in preoperative chemoradiation for locally advanced rectal cancer.	Page:129—136
4. Deformable image registration in radiation therapy.	Page:101—111
5. The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea.	Page:112—120
6. In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boost.	Page:121—128
7. Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment.	Page:144—152
8. Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study.	Page:153—162
9. Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report.	Page:180—184
10. Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy.	Page:163—171
11. Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors.	Page:172—179